Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

Dutch Initiative on Crohn’s and Colitis (ICC), J. E. Kreijne^*, R. L. Goetgebuer, N. S. Erler, N. K. De Boer, A. G. Siebers, G. Dijkstra, F. A. van Kemenade, F. Hoentjen, B. Oldenburg, A. E. van der Meulen, C. I.J. Ponsioen, M. J. Pierik, C. J. van der Woude, A. C. de Vries^*